{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:29:15Z","timestamp":1790108955908,"version":"4.0.1"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Fibroblast activation protein (FAP) is a new promising molecular target for theragnostic approach. FAP inhibitors (FAPIs) labeled with <jats:sup>177<\/jats:sup>Lu could be potentially a therapeutic radiopharmaceutical. Here, we presented the experience of 4 cycles of <jats:sup>177<\/jats:sup>Lu-FAPI in a 67-year-old man with an unresectable mediastinal sarcoma.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005255","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T23:00:50Z","timestamp":1716937250000},"page":"e334-e337","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["First Experience of Radionuclide Therapy With 177Lu-FAPI-2286 in a Patient With Metastatic Mediastinal Sarcoma"],"prefix":"10.1097","volume":"49","author":[{"given":"Seyedeh Somayyeh","family":"Banihashemian","sequence":"first","affiliation":[{"name":"Cancer Research Center, Shahid Beheshti University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadese","family":"Bayat","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Shohada Tajrish Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Pirayesh","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Shohada Tajrish Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghasemali","family":"Divband","sequence":"additional","affiliation":[{"name":"Khatam PET-CT Center, Khatam-al-Anbia Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolghafar","family":"Abolhosseini","sequence":"additional","affiliation":[{"name":"Parsisitope Company, Tehran, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Esmaeel","family":"Akbari","sequence":"additional","affiliation":[{"name":"Cancer Research Center, Shahid Beheshti University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2174\/156652412803833607","article-title":"Fibroblast activation protein in remodeling tissues","volume":"12","year":"2012","journal-title":"Curr Mol Med"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-0-12-394308-8.00003-0","article-title":"Fibroblast activation protein-\u03b1: a key modulator of the microenvironment in multiple pathologies","volume":"297","year":"2012","journal-title":"Int Rev Cell Mol Biol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1097\/RLU.0000000000004051","article-title":"Fibroblast activation protein inhibitor imaging and therapy in a patient with multiple endocrine neoplasia type 2A syndrome","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00259-023-06144-0","article-title":"Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre) clinical studies","volume":"50","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib5-20250621","first-page":"65","article-title":"Novel fibroblast activation protein inhibitor-based targeted theranostics for radioiodine-refractory differentiated thyroid cancer patients: a pilot study","volume":"32","year":"2022","journal-title":"Thyroid"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib7-20250621","first-page":"727","article-title":"Initial clinical experience with (90)Y-FAPI-46 radioligand therapy for advanced-stage solid tumors: a case series of 9 patients","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cpet.2023.03.001","article-title":"Fibroblast activation protein inhibitor (FAPI)-PET imaging in sarcoma","volume":"18","year":"2023","journal-title":"PET Clin"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2559.2009.03399.x","article-title":"Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours","volume":"55","year":"2009","journal-title":"Histopathology"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1073\/pnas.91.12.5657","article-title":"Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers","volume":"91","year":"1994","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:01:16Z","timestamp":1750532476000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005255","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}